What is the approach to managing a 2.3 mm thick skin Squamous Cell Carcinoma (SCC) with no apparent connection to the epidermis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Cutaneous Squamous Cell Carcinoma Without Epidermal Connection

Wide local excision with a 2-cm margin is the recommended treatment for a 2.3 mm thick squamous cell carcinoma (SCC) at the left temple, even when there is no apparent connection to the epidermis. 1

Understanding the Unusual Presentation

  • SCCs typically present as indurated nodular keratinizing or crusted tumors that may ulcerate, but can occasionally present with unusual clinical features including no apparent connection to the epidermis 1, 2
  • Unusual presentations of SCC can lead to delayed diagnosis and potentially worse outcomes, especially when the clinical appearance is misleading 2
  • Any suspicious lesion that is palpable despite normal-appearing overlying skin warrants tissue sampling for definitive diagnosis 2

Risk Assessment

  • A 2.3 mm thick SCC is considered intermediate risk, as tumors >4 mm in depth have significantly higher metastatic potential (45.7% vs 6.7% for tumors <4 mm) 1
  • Location on the temple (head and neck region) is a higher risk factor for recurrence and metastasis 3
  • The lack of epidermal connection is unusual and may represent an aggressive variant, requiring careful evaluation 4

Diagnostic Approach

  • Complete excisional biopsy with histopathological evaluation is essential to:
    • Confirm the diagnosis and rule out other entities 1
    • Determine the depth of invasion, differentiation, and presence of perineural or vascular invasion 1
    • Evaluate for aggressive histologic subtypes (such as spindle cell variants) 4

Treatment Algorithm

1. Surgical Management (Primary Approach)

  • Wide local excision with a 2-cm margin is the treatment of choice 1
  • Consider the following during surgical planning:
    • Use marker sutures for specimen orientation 1
    • Mount the specimen appropriately for histopathological evaluation 1
    • Ensure histopathological evaluation determines lateral and deep margin clearance 1

2. Consider Mohs Micrographic Surgery

  • May be appropriate when:
    • The tumor borders are difficult to define clinically 1
    • Tissue preservation is important for functional or aesthetic reasons 1, 5
  • Note: Interpretation of frozen sections may be challenging in unusual SCC presentations 1

3. Regional Lymph Node Evaluation

  • Perform clinical examination of regional lymph nodes 1
  • If lymph nodes are palpable, obtain ultrasound-guided fine needle aspiration (FNA) 1
  • Consider sentinel lymph node biopsy for high-risk features 1

Follow-up and Surveillance

  • Regular follow-up examinations every 3-6 months for the first 2 years 1
  • Evaluate for:
    • Local recurrence at the primary site 1
    • Regional lymph node involvement 1
    • Distant metastases in high-risk cases 1

Special Considerations for This Case

  • The unusual presentation without epidermal connection requires careful histopathological evaluation to rule out aggressive variants like spindle cell SCC 4
  • The 2.3 mm thickness places this tumor at intermediate risk, but the unusual growth pattern may suggest more aggressive behavior 1, 3
  • If the tumor is near major blood vessels or nerves on the temple, imaging (MRI preferred) should be considered to assess the extent of invasion 1

Pitfalls to Avoid

  • Don't mistake the normal-appearing epidermis for benign disease; the palpable mass requires thorough evaluation 2
  • Don't underestimate the risk of metastasis based solely on tumor thickness; unusual growth patterns may indicate more aggressive behavior 3, 4
  • Don't delay definitive surgical treatment, as SCC can progress to invasive disease with metastatic potential 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of high-risk squamous cell carcinoma of the skin.

Expert review of anticancer therapy, 2011

Research

An unusual presentation of an aggressive spindle cell skin cancer.

The Journal of community and supportive oncology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.